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doi:10.1016/j.ejvs.2010.07.020Abstract Objectives: To assess causative pathogens and surgical outcomes in patients with
primary infected aorto-iliac aneurysms at our institution.
Design: Retrospective study of patients treated at a university hospital between 1992 and
2009.
Results: We identified 26 patients (median age, 63 years) with primary infected aneurysms on
the aorta (descending thoracic, nZ 2; thoraco-abdominal, nZ 3; suprarenal, nZ 2; infrare-
nal, n Z 15) or iliac arteries (n Z 4). Among them, 22 were symptomatic, including 13 with
ruptured aneurysms. The causative organisms, identified in 25/26 patients, were Campylo-
bacter fetus, n Z 6; Streptococcus pneumoniae, n Z 4; Listeria, n Z 3; Salmonella,
n Z 2; Mycobacterium tuberculosis, n Z 2; Staphylococcus aureus, n Z 1; and other,
n Z 7. Immune suppression was a feature in 10 (38.4%) patients. Revascularisation was per-
formed in situ in 23 patients (10 allografts, eight grafts, three superficial femoral veins, and
2 stentgrafts) and by extra-anatomic bypass in three patients.
Hospital mortality was 23% (in situ group, 17.4%; extra-anatomic group, 66.7%; c2 Yates,
P Z 0.24). During follow-up in the 20 survivors (median, 48.5 months), there were two non-
infection-related deaths (five and 24 months) and six (30%) vascular complications.
Conclusions: The bacteriological spectrum of primary infected aorto-iliac aneurysms was
wider than previously reported. The availability of new diagnostic tests and increased preva-
lence of immunosuppression may explain this finding.
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New Bacteriology of Primary Infected Aneurysms 583Primary infected aorto-iliac aneurysms include infected
pre-existing aneurysms and aneurysms caused by bacterial
aortitis. Although they contribute only 1e3%1,2 of all aorto-
iliac aneurysms, they raise challenges for vascular
surgeons, because they are associated with high morbidity
and mortality rates. Previous studies found that Salmo-
nella, Staphylococcus and Streptococcus were the main
pathogens involved.2e5 Data from our institution suggested
changes in recent years in the organisms causing primary
infections of aorto-iliac aneurysms.6,7
The objective of this study was to review our experience
with patients managed for primary infected aorto-iliac
aneurysms over a 17-year period, with the goal of evalu-
ating the causative organisms and surgical outcomes.
Patients and Methods
We identified all patients managed at the vascular surgery
department of our institution (Henri Mondor Teaching
Hospital, Cre´teil, France) between 1992 and2009 for primary
infected aortic or iliac aneurysm distal to the left subclavian
artery. Primary aorto-iliac aneurysm infectionwas diagnosed
in patients with (1) clinical evidence of infection (fever, pain
and leucocytosis), and (2) intra-operative findings of
inflammation and pus and (3) positive blood or aneurysmwall
cultures. We also included patients who had negative
cultures if they had convincing operative findings, fever of
unknownorigin and at least 1weekof preoperative antibiotic
treatment. Finally, patients managed with endovascular
repair were included if they had suggestive clinical symp-
toms, positive bloodcultures andcomputed tomography (CT)
or magnetic resonance imaging (MRI) evidence of infection
(rapid increase in aneurysm diameter, saccular aneurysm,
festooned and irregular arterial contour, abscess, vertebral
lysis or retroperitoneal collection without evidence of
rupture). We did not include patients with aneurysms of the
ascending aorta, aortic arch or aortic branches; prosthetic
graft infections; or positive aneurysm wall cultures without
evidence of active infection.
We collected the study data via retrospective review of
the prospective database of our vascular surgery depart-
ment, according to institutional review board protocols
specific to our institution. Additional data were collected
from the patient medical records. We recorded the
following data: age, gender, site of the infected aneurysm,
clinical presentation (pain, leucocytosis, fever and C-
reactive protein (CRP) elevated to at least twice the
baseline value), risk factors (atherosclerosis, diabetes and
immunodeficiency), history of recent infection, results of
blood and intra-operative cultures, results of imaging
studies, operative findings and techniques, duration of
antibiotic therapy, in-hospital and long-term mortality, and
short- and long-term surgical complications including graft
infection and persistent signs of infection.
Follow-up data were obtained from outpatient records.
We recorded the findings from imaging studies (Duplex
scan, CT, MRI) and laboratory tests (e.g., blood cell counts
and CRP). Information about patients, who died during
follow-up, was obtained from autopsy reports, official
death certificates and interviews with the patients’ physi-
cians or relatives.Results
From March 1992 to April 2009, 26 patients with primary
infected aortic or iliac aneurysms were managed at our
institution. Table 1 shows the main symptoms, micro-
organisms, aneurysm features, treatments, and outcomes.
Clinical patterns
There were 19 men and seven women (sex ratio, 2.71:1)
with a mean age of 63 years (range, 23e86 years). Table 2
lists the clinical features, laboratory findings and co-
morbidities. Prior hospital admission was noted in three
patients, among whom one had a Staphylococcus aureus leg
abscess, one had Aspergillus nephropathy after heart
transplantation and one had Streptococcus endocarditis 1
month before admission for the aneurysm infection. In
these three patients, we found the same organisms in the
primary infected aneurysms.
Preoperative imaging
Preoperative imaging was performed in all patients, using
either CT (n Z 24) or MRI (n Z 2). Table 3 lists the main
findings. The aneurysm was located at the iliac artery in
four (15%) patients and at the infrarenal aorta in 15 (58%).
One patient had a pararenal aneurysm treated via a retro-
peritoneal approach and another a suprarenal aneurysm
treated via a thoraco-abdominal approach. In addition,
three (11%) patients had thoraco-abdominal aneurysms and
two (8%) had aneurysms limited to the descending aorta. Of
note, one of the patients with thoraco-abdominal aneu-
rysms also had a primary infected aneurysm of the common
femoral artery.
Bacteriological findings
Table 1 lists the bacteriological findings. Positive cultures
were obtained from the aneurysm wall or surrounding
tissues in 22 (84.6%) patients and/or from blood in 16
(61.5%) patients, and 25 (96%) patients had at least one
positive culture. In the patient with negative aneurysm wall
and blood cultures, preoperative serological tests estab-
lished a definitive diagnosis of Q fever.8 In one patient, two
organisms were found, Streptococcus oralis by the aneu-
rysm wall culture and active tuberculosis by histopathogical
examination of the operative specimen (epithelioid granu-
lomas and caseous necrosis).
Surgical findings
Of the 26 aneurysms included in the study, five (19.2%)
were ruptured at the time of surgery. Of the three patients
with non-contained rupture and shock, one had an aneu-
rysm of the visceral aorta ruptured into the pleural space
and two had infrarenal aneurysms, ruptured into the
abdominal cavity and retroperitoneal cavity, respectively.
Of the two remaining ruptured aneurysms, one was an
infrarenal aneurysm ruptured into the third duodenum,
with severe haematemesis, and the other was a thoracic
Table 1 Main features in the 26 study patients.
Patient # Age (sex) Bacteria BC AWC Location Intervention 30-day deaths
day (cause)
Outcome Follow-up
(months)
Extra-anatomic bypass
1 62 (F) Salmonella þ  IRA Dacron (axillo-femoral bypass) 5 (sepsis) e e
2 37 (M) Propioni-bacterium þ
Coryne-bacterium
 þ IA SFV* (femoro-femoral bypass) e e 48
3 37 (M) Streptococcus pneumoniae þ þ IA GSV** (femoro-femoral bypass) 16 (valve
detachment)
e e
In situ bypass
4 69 (M) Campylobacter fetus þ þ IRA Dacron (aorto-biiliac bypass) e Graft infection
(D21) (sepsis)
34
5 69 (M) Campylobacter fetus þ þ IRA Silver (aorto-bifemoral bypass) e Graft infection
(D15) (sepsis)
28
6 76 (M) Campylobacter fetus  þ IRA Dacron (aortic tube graft) e Death unrelated
to infection
5
7 76 (M) Campylobacter fetus þ  IRA Zenith bifurcated stentgraft 15 (sepsis) e e
8 78 (M) Campylobacter fetus þ þ IRA Allograft (aortic tube graft) e e 38
9 79 (M) Campylobacter fetus þ  IA Zenith aorto mono-iliac stentgraft,
femoroefemoral bypass
e e 100
10 59 (F) Streptococcus pneumoniae þ þ DTA Allograft (aortic tube graft) e e 36
11 62 (M) Streptococcus pneumoniae  þ TAA Allograft (aortic tube graft,
LRA**** bypass)
e Severe bleeding (D 11),
paraplegia, Haemorrhage
(2 m, stentgraft)
10
12 76 (M) Streptococcus pneumoniae þ þ IRA Allograft (aortic tube graft) e e 16
13 64 (M) Listeria monocytogenes þ þ IRA Allograft (aortic tube graft) e e 16
14 64 (M) Listeria monocytogenes þ þ IRA Allograft (aortic tube graft) e Collection (6 m) 81
15 65 (M) Listeria monocytogenes þ þ IRA Silver soaked with rifampin
(aorto-biiliac bypass)
e Graft infection
(19 m) (sepsis)
19
16 23 (F) Mycobacterium tuberculosis  þ TAA Dacron (aortic tube graft) e e 170
17 37 (F) Mycobacterium tuberculosis  þ IRA Silver (aortic tube graft) e e 16
18 77 (M) Streptococcus oralis,
Mycobacterium tuberculosis
 þ IRA SFV* (aorto-biilac bypass) e Collection (3 m) 112
19 40 (M) Aspergillus þ þ IA Allograft (aorto- bifemoral) 5 (colonic
ischaemia)
e e
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Figure 1 Right psoas abscess.
Figure 2 Penetrating ulcer with gas in the aortic wall (arrows).
New Bacteriology of Primary Infected Aneurysms 585a-ortic aneurysm ruptured into the lung. Chronic contained
rupture with diffusion to peri-aortic tissues was found in
eight (31%) patients. The remaining 13 (50%) patients had
unruptured aorto-iliac aneurysms at the time of surgery.
Operative treatment
All patients underwent primary vascular reconstruction.
The type of procedure was at the discretion of the oper-
ating surgeon, who made decisions based on the features in
each individual patient and on the availability of autologous
or allogeneic graft material.
The surgical procedures were classified as emergent
(n Z 10), quasi-emergent (within 48 h of surgical vascular
consultation, n Z 6), or elective (n Z 10). In situ aortic
reconstruction was performed in 23 (88.4%) patients and
extra-anatomic bypass surgery in three (11.6%) patients. In
the in situ group, the bypass materials were as follows:
silver-coated polyester graft (InterGard Silver; Inter-
Vascular, La Ciotat, France) in five (22%) patients, including
one managed with a rifampin-soaked graft; various stan-
dard rifampin-soaked Dacron prostheses in four (17%)
patients, aortic allogeneic material in 10 (43%) patients,
Table 2 Main features in the study patients.
N %
Clinical presentation
Fever 21 80%
Pain 22 84.6%
Haemorrhagic shock 3 11.5%
Renal failure 3 11.5%
Respiratory failure 1 3.8%
Immunodepression 10 38.4%
Malignant disease 7 26.9%
Immunosuppressive therapy 2 7.6%
Long-term steroid medication 1 3.8%
Diabetes mellitus 6 23%
Cardiovascular risk factor 23 88.4%
Laboratory features
Leukocytosis 16 61.5%
High CRP level 13 50%
CRP, C-reactive protein in serum.
586 J. Brossier et al.autologous superficial femoral vein in two (9%) patients and
aortic stentgraft in two (9%) patients. Of the three patients
managed by extra-anatomic bypass surgery, one patient
with an infrarenal aortic aneurysm was treated by thoracic
aorta ligation and axillofemoral bypass and two patients
with right common iliac artery aneurysms were treated by
ligation and femoro-femoral venous bypass (great saphe-
nous vein and superficial femoral vein, respectively).
Extensive debridement of the aneurysm and adjacent
necrotic material was performed in 23 (88.4%) patients. In
addition, the following vascular procedures were per-
formed in seven patients: aorto-renal artery bypass
(n Z 3), re-implantation of the inferior mesenteric artery
(nZ 3), and celiac-to-left renal artery bypass (nZ 1). The
graft was protected by omental flap interposition in seven
(31%) patients, Vicryl mesh in one (4%) patient, and simple
retroperitoneal closure in nine (38%) patients. In six (27%)
patients, graft protection was not necessary (descending
thoracic aorta aneurysms, stentgraft, or extra-anatomic
bypass). Finally, three patients had combined abdominal
procedures (duodenal suture with jejunal bypass, right
nephrectomy and Hartmann procedure, respectively).
Antibiotic therapy
In 14 (54%) patients, antibiotics were taken before surgery,
for a mean of 9.9 days (range, 3e21 days). AntibioticTable 3 Preoperative imaging findings.
Preoperative imaging n Percentage
Ruptured 11 42.3%
Contained 4 15.4%
Non-ruptured 15 57.7%
Saccular aneurysms 6 23%
Abscess (Fig. 1) 3 11.5%
Gas in the aortic wall (Fig. 2) 2 7.6%therapy was initiated just before surgery in the remaining
12 patients. Moderate- or broad-spectrum empirical anti-
biotics (usually a penicillin with an inhibitor and an ami-
noglycoside) were given intravenously and the treatment
was subsequently adjusted based on microbiological study
findings. Mean duration of intravenous antibiotic therapy
was 15 days (range 0e30 days). Oral antibiotics were then
given for a mean duration of 11 weeks (range, 1e52 weeks).
Early outcomes
Six (23%) patients died in the perioperative period, four (4/
23, 17.4%) following in situ bypass and two (2/3, 66.7%)
following extra-anatomic bypass. No patients died in the
operating room; all six deaths occurred between days 5 and
30 (mean, 13 days). Two patients managed with in situ
bypass died from multi-organ failure associated with colon
ischaemia 5 and 7 days after surgery, respectively. Fatal
septic shock occurred in two other patients (one managed
with an extra-anatomic bypass and 1 with a stentgraft), on
postoperative days 5 and 14, respectively. One patient,
with iliac primary aneurysm infection related to endo-
carditis treated with two bioprostheses, died 16 days after
extra-anatomic bypass surgery, from acute pulmonary
oedema due to valve detachment. The remaining patient
underwent in situ bypass combined with right nephrectomy
for septic rupture of the renal artery origin and right pyo-
nephrosis. Six days after surgery, she developed a left
kidney infection and thrombosis of the left renal vein and
inferior vena cava with pulmonary embolism. Despite left
nephrectomy, inferior vena cava thrombectomy, haemo-
dialysis, and surgery 3 days later to treat retroperitoneal
bleeding, she died on day 30 from severe bleeding after
evacuation of a large retroperitoneal abscess.
Major postoperative complications occurred in 14 (54%)
patients. They consisted of transient renal failure (n Z 6,
23%), permanent renal failure (n Z 3, 12%), respiratory
failure requiring prolonged ventilation (n Z 3, 12%),
pneumonia (nZ 2, 8%) and arrhythmia (nZ 1, 4%). Surgical
complications occurred in nine (34.6%) patients and con-
sisted of severe bleeding (n Z 3), colon ischaemia (n Z 3)
and paraplegia (n Z 1). Two patients with ruptured
infrarenal aneurysms infected with Campylobacter fetus
experienced graft infection requiring emergency surgery;
one was managed with a Dacron aorto-biiliac bypass graft
and the other with a silver-coated polyester aorto-bife-
moral bypass graft. They remained febrile after surgery
despite appropriate antibiotic therapy. CT showed fluid
around the graft in both patients and gas around the graft in
one patient. Both patients were managed with total graft
removal followed by reconstruction with aorto-femoral and
femoro-femoral bypasses using autologous superficial
femoral vein, 2 and 3 weeks after the first surgical proce-
dure, respectively, without further complications.
Late outcomes
Mean clinical follow-up was 46 months (range, 3e170
months) in the 20 survivors. One patient was lost to follow-
up 3 months after surgery. Two patients died during follow-
up, 5 and 26 months after surgery, respectively, from
unrelated causes: one of them had no evidence of recurrent
New Bacteriology of Primary Infected Aneurysms 587infection by follow-up CT 2 months before death and the
other had no clinical or laboratory evidence of infection at
follow-up 6 months before death.
Late vascular complications, including two related to the
graft, occurred in six (30%) of the 20 survivors. One of the
patients with late graft-related complications had been
treated for an infrarenal aortic aneurysm with recovery of
Listeria from aneurysm wall cultures. The procedure had
consisted of total aneurysmexcision, silver-coated polyester
aorto-biiliac bypass grafting, and a Hartmann procedure
required by intra-operative colon ischaemia. The only post-
operative complicationwas arrhythmia. However, 19months
later, he was admitted for persistent fever with elevated
inflammation markers but negative blood cultures. CT
showedaperi-prosthetic collectionwith increaseduptake by
positron-emission tomography (PET)/CT. Surgery was per-
formed for total graft excision and aorto-biiliac bypass
grafting using allogeneic material. There were no post-
operative complications. The other patient with a late graft-
related complication had been managed with in situ bypass
grafting of allogeneic material for a thoraco-abdominal
aneurysm infected with Streptococcus pneumoniae. On day
11, severe bleeding due to a tear in the suture connecting the
two allografts required further surgery, which was compli-
cated by paraplegia. Two months later, he was referred to
our department on an emergency basis for haemothorax and
pneumopathy. CT showed contrast material leakage
between the two allografts. He was treated with stentgraft
insertion via the left subclavianartery andhadnoevidenceof
recurrence 8 months after this third procedure. Of the
remaining four patients with late vascular complications,
three had persistent deep collections about the graft (two
autologous superficial femoral vein grafts and one allograft)
with no evidence of infection at follow-up (3e112 months).
These patients were not considered as having graft-related
complications. The remaining patient also had a vascular
complication unrelated to the graft that consisted in post-
ostial stenosis of the left renal artery stenosis treated with
angioplasty and stenting.
Finally, one patient treated with in situ allogeneic
bypass grafting for an infrarenal aortic aneurysm infected
with C. fetus had elevated laboratory markers for inflam-
mation for the first 6 postoperative months, with no
evidence of persistent infection (no leucocytosis, negative
blood cultures and no collections about the graft).Discussion
We found a higher rate of atypical micro-organisms
compared with previous case series,2e5 in which Staphylo-
coccus, Salmonella, and Streptococcus predominated.
Among the 26 patients, the majority had infections related
to other micro-organisms including C. fetus, Listeria mon-
ocytogenes, Mycobacterium tuberculosis, Coxiella burnetii
and Aspergillus species. Twelve patients were infected
with more common bacteria, essentially Streptococcus
species and minor Salmonella. S. aureus was found in
a single patient.
This difference may be explained in part by the high
proportion of patients with organisms recovered from blood
and/or tissue cultures in our study (96%). In other large caseseries, 14e40% of patients had negative bacteriological
studies. Furthermore, the identification of the most
common bacteria in our series, that is, Campylobacter and
Listeria, is known to be difficult, as it requires prolonged
culturing on enriched, micro-aerophilic media.9e12
However, the use of sensitive bacteriological techniques
may not fully explain the higher proportion of atypical
bacteria and the lower rate of negative bacteriological
studies in our case series. Mean age in our population (63
years) was similar to that in other large studies (range,
64e71 years).2e5 However, one-third of our patients had
major risk factors for infection, usually immunodepression
(related to cancer, immunosuppressive therapy and/or
long-term steroid therapy). However, comparisons with
previous studies are difficult because the criteria used to
define immunosuppression vary widely in the literature.
Interestingly, serological testing and histopathological
analysis of surgical samples yielded a diagnosis of Q fever in
one patient and of tuberculosis in another.
Recent reports of high mortality rates2 are mainly
explained by a high proportion of patients with ruptured
aneurysms. In a study of 22 patients, who had infected aortic
aneurysms treated without aortic resection, mortality was
36% in Salmonella-infected patients and 82% in patients
infected with other organisms.13 Surgical excision of the
infected aortic aneurysm with in situ or extra-anatomic
revascularisation remains the reference standard.
In our case series, the difference in postoperative
mortality between the extra-anatomic group (66.7%) and the
in situ group (17.4%) was not statistically significant, perhaps
because of our small sample size. The clinical condition of
the patient plays a role in the decision to perform extra-
anatomic bypass grafting, which may explain why 2 of the 3
patients treated using this procedure died. These two
patientswere among the fourwith iliac aneurysms.However,
one of them died from a complication that was unrelated to
the aneurysm (heart valve detachment). Despite the lack of
studies comparing extra-anatomic and in situ repair, most
authors recommend in situ repair whenever feasible. The
efficacy of standard Dacron prostheses for in situ replace-
ment of primary infected aortic aneurysms seems limited. In
the literature, the failure rate ranged from 5% to 30%.3,4,14,15
The role for rifampin-bonded grafts in the in situ repair of
primary infected aneurysms, suggested by Gupta et al.16 in
1996, is still debated. A randomised trial of rifampin-bonded
extra-anatomic Dacron grafts failed to demonstrate a clear
benefit.17 In our study, these grafts failed in 1 of 4 patients.
Although experimental18 and clinical19e21 data suggest that
silver-coated grafts may be superior to rifampin-bonded or
standard grafts, their role is difficult to assess, asmost series
mix a limited number of primary infected aortic aneurysms
with a large number of prosthetic graft infections. In our case
series, silver-coated grafts failed in 2 of 5 patients.
Our experience with endovascular repair of primary
infected aorto-iliac aneurysms is limited. A recent review
of 47 cases showed that 16% of patients died and 22.9%
experienced persistent infection.22 Most of the recent case
series23e26 found high aneurysm-related mortality rates, as
well as high infection-recurrence rates despite prolonged
antibiotic therapy. Stent-graft insertion might serve as
a bridge towards secondary allograft replacement, as
recently suggested by Inoue.27
588 J. Brossier et al.In our experience, early and late complications occurred
only after synthetic graft replacement surgery (4/11
patients, included two with a silver-coated graft, one with
a rifampin-soaked graft and one with a stentgraft). There
were no complications related to autologous vein repair,
and the only complication after allogeneic graft surgery
was bleeding with no evidence of infection. We therefore
recommend the use of autologous veins or allogeneic grafts
for in situ repair whenever possible.
Conclusion
The bacteriological spectrum of primary infected aorto-
iliac aneurysms is wider than previously reported, due to
improvements in diagnostic tests and to an increasing
number of patients with immunodepression. In situ
replacement provides the best results. Autologous material
and allogeneic grafts should be preferred over synthetic
grafts. Endovascular repair should be limited to high-risk
patients, in whom it may serve as a bridge towards allo-
geneic graft replacement.
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